Health Care REIT (NYSE:HCN) had its price objective trimmed by Barclays from $72.00 to $60.00 in a research report released on Wednesday morning, Analyst Ratings News reports. Barclays currently has an overweight rating on the stock. HCN has been the subject of a number of other recent research reports. Analysts at BMO Capital Markets downgraded […]
Health Care REIT Price Target Cut to $60.00 by Analysts at Barclays (HCN) is a post from: Zolmax
The post Health Care REIT Price Target Cut to $60.00 by Analysts at Barclays (HCN) appeared first on Zolmax.